Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Innovating Urban Mosquito Control: Introducing Human-Controlled Breeding Sites as a Component of Integrated Mosquito Management (IMM)

View ORCID ProfileGuillermo A. Baigorria, View ORCID ProfileConsuelo C. Romero
doi: https://doi.org/10.1101/2024.05.14.24307332
Guillermo A. Baigorria
1Next Season Systems LLC, Department of Research and Development, Lincoln, NE 68506, USA
2Gikarix SAC, Department of Research and Development. La Molina, Lima, 15024, Peru
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Guillermo A. Baigorria
  • For correspondence: gbindy6{at}gmail.com
Consuelo C. Romero
1Next Season Systems LLC, Department of Research and Development, Lincoln, NE 68506, USA
2Gikarix SAC, Department of Research and Development. La Molina, Lima, 15024, Peru
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Consuelo C. Romero
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

This study introduces a novel method for mosquito control tailored specifically for urban and suburban areas, addressing their unique challenges. The concept of Human-Controlled Breeding Sites (HCBS) is presented as an innovative approach to reducing mosquito populations by providing controlled oviposition sites within households. The paper is structured into three main components. The first details the meticulous development of the HCBS method, the second explores the intricate development of the HCBS device, crucial for effective implementation of the HCBS approach. Finally, the experiment validating the HCBS methodology is described, offering insights into its practical application and efficacy in mosquito population control. Our proposal emphasizes the importance of considering mosquito needs, behavior and preferences in designing effective mosquito control strategies. Gravid mosquitoes must find a suitable place for oviposition, and HCBS provides an easy-access controlled environment for them to do so within households. Contrary to the commonly current recommendation to destroy all possible locations where mosquitoes can lay their eggs, the HCBS methodology provides an opportunity for gravid mosquitoes to oviposit their eggs without being deterred by chemical odors or dead larvae or pupae. It involves waiting for a timespan before effectively collecting and destroying the individuals in one concerted effort with zero impact on the environment and at minimal cost. Successful deposition of eggs by gravid mosquitoes into HCBS devices, followed by their destruction within the designated timeframe, validates the system’s efficacy in disrupting the mosquito life cycle. Moreover, our findings demonstrate the significant influence of color selection on HCBS effectiveness, with green HCBS devices being the preferred choice, although not an indispensable condition for oviposition. These integrated components offer a comprehensive understanding of the HCBS approach, effectively bridging the gap between methodological development, device design, and practical application. The findings underscore HCBS as a valuable addition to mosquito control strategies, with potential applications in diverse environments. Further research is essential to delve into and model the long-term effectiveness of HCBS, aiming to optimize its design for maximum efficacy and scalability. This includes studying its performance over extended periods and refining the design parameters to enhance its functionality and widespread applicability including the use of disaster risk management systems.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • Section 4.2.2 was modified after new findings: 'After tallying the larvae and pupae across all HCBS devices, a significant statistical difference was observed in the number of specimens collected, particularly between the green HCBS device and those of other colors. This difference can be attributed to mosquitoes' exclusive initial preference for ovipositing in the green device, as detailed in Table 1. Counting ceased after 50 days when no oviposition was detected in HCBS devices of other colors, although the devices remained operational in the laboratory. However, subsequent inspections revealed the presence of larvae in the red HCBS device. Two weeks later, larvae were also found in the white device, followed by the black device a week after, and eventually in the blue device. Although the counting had already stopped, preventing precise quantification of individuals, it is crucial to note these later observations. These findings suggest that while green is the preferred color for oviposition, it is not an indispensable condition for gravid mosquitoes to oviposit.' Other small changes were updated based on the same new findings.

Data Availability

All data produced in the present work are contained in the manuscript

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Back to top
PreviousNext
Posted August 20, 2024.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Innovating Urban Mosquito Control: Introducing Human-Controlled Breeding Sites as a Component of Integrated Mosquito Management (IMM)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Innovating Urban Mosquito Control: Introducing Human-Controlled Breeding Sites as a Component of Integrated Mosquito Management (IMM)
Guillermo A. Baigorria, Consuelo C. Romero
medRxiv 2024.05.14.24307332; doi: https://doi.org/10.1101/2024.05.14.24307332
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Innovating Urban Mosquito Control: Introducing Human-Controlled Breeding Sites as a Component of Integrated Mosquito Management (IMM)
Guillermo A. Baigorria, Consuelo C. Romero
medRxiv 2024.05.14.24307332; doi: https://doi.org/10.1101/2024.05.14.24307332

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Public and Global Health
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)